JianJiong Gao

Associate Attending
JianJiong Gao

Email

[email protected]

Dr. Gao’s research interests are rooted in the quest to harness the power of molecular and clinical data to accelerate cancer research and revolutionize cancer care. His primary focus is on building effective methods and infrastructure to bridge the gap between complex data and actionable insights for cancer researchers and clinicians. As an Associate Attending in the Computational Oncology Service and the Head of Engineering for the Cancer Data Science Initiative (CDSI) at Memorial Sloan Kettering Cancer Center, he lead a team to develop sophisticated methods and platforms to integrate multimodal real world patient data and apply advanced artificial intelligence (AI) methods to answer research and clinical questions. Notable projects co-led/founded by Dr. Gao include cBioPortal, OncoKB, Genome Nexus, and MSK MIND. These projects and new efforts in CDSI are geared towards creating a clinical decision support infrastructure that provides clinicians with data-driven insights into patients’ diseases, ultimately informing and enhancing clinical decisions.

Publications

  1. de Bruijn I, Kundra R, Mastrogiacomo B, Tran TN, Sikina L, Mazor T, Li X, Ochoa A, Zhao G, Lai B, Abeshouse A, Baiceanu D, Ciftci E, Dogrusoz U, Dufilie A, Erkoc Z, Garcia Lara E, Fu Z, Gross B, Haynes C, Heath A, Higgins D, Jagannathan P, Kalletla K, Kumari P, Lindsay J, Lisman A, Leenknegt B, Lukasse P, Madela D, Madupuri R, van Nierop P, Plantalech O, Quach J, Resnick AC, Rodenburg SYA, Satravada BA, Schaeffer F, Sheridan R, Singh J, Sirohi R, Sumer SO, van Hagen S, Wang A, Wilson M, Zhang H, Zhu K, Rusk N, Brown S, Lavery JA, Panageas KS, Rudolph JE, LeNoue-Newton ML, Warner JL, Guo X, Hunter-Zinck H, Yu TV, Pilai S, Nichols C, Gardos SM, Philip J; AACR Project GENIE BPC Core Team, AACR Project GENIE Consortium; Kehl KL, Riely GJ, Schrag D, Lee J, Fiandalo MV, Sweeney SM, Pugh TJ, Sander C, Cerami E, Gao J, Schultz N. Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal. Cancer Res. 2023 Dec 1;83(23):3861-3867. doi: 10.1158/0008-5472.CAN-23-0816. PMID: 37668528
  2. de Bruijn I, Li X, Sumer SO, Gross B, Sheridan R, Ochoa A, Wilson M, Wang A, Zhang H, Lisman A, Abeshouse A, Zhang E, Thum A, Sadagopan A, Heins Z, Kandoth C, Rodenburg S, Tan S, Lukasse P, van Hagen S, Fijneman RJA, Meijer GA, Schultz N, Gao J. Genome Nexus: a comprehensive resource for the annotation and interpretation of genomic variants in cancer. JCO Clin Cancer Inform. 2022 Feb;6:e2100144. doi: 10.1200/CCI.21.00144. PMID: 35148171
  3. Chakravarty D*, Gao J*, et al. OncoKB: A Precision Oncology Knowledge Base. JCO PO. 2017:1,1-16. PMCID: PMC5586540.
  4. Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1. PMCID: PMC4160307.

To view more publications, visit PubMed

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

JianJiong Gao discloses the following relationships and financial interests:

  • Caris Life Sciences
    Equity
  • Manifold Inc.
    Professional Services and Activities

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures